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The International HapMap Consortium has determined the linkage disequilibrium (LD) patterns of four major human populations. The aim of
our investigation was to compare the LD patterns of the HapMap CEPH (Centre d'Etude du Polymorphisme Humain) samples with a family-based
cohort of similar ancestry to determine its usefulness as a reference population for disease association studies. We examined four genomic regions
on chromosomes 7q, 12p, and 14q totaling 14.3 Mb, initially identified in our linkage study of obesity and the metabolic syndrome. Near identical
patterns of LD were detected in both populations. Furthermore, tagSNPs selected based on the HapMap CEPH cohort data capture over 98% of the
variants at an r2 > 0.8 in the disease cohort. This confirms the usefulness of the CEPH cohort of the HapMap as a reference sample for further
investigations into the genomic variation of populations of Northern European descent.
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common form of genetic variation, with approximately 7 million
at a minor allele frequency (MAF) above 5% estimated to be
present in the human genome [1]. Accordingly, they are the
marker of choice for disease association studies due to their
prevalence and ease of genotyping. The availability of SNPs has
generated a great deal of optimism for the detection of genes
underlying complex human diseases. However, the identifica-
tion of a quantitative trait locus (QTL) is merely the first step
down a long road of genetic discovery and can yield any number
of candidate genes (not counting potential regulatory elements
located in the QTL) as putative sites of causal variants. It is this
identification of the causal variant(s) that remains difficult.
The realization that the genome is split into discrete blocks of
high and low linkage disequilibrium (LD) [2–4] and that the
majority of common genetic variation can be captured by typing
a subset of SNPs [5] has improved our ability to detect potential
causal variants or the haplotypes they are associated with. The
HapMap project has mapped the patterns of LD across the
human genome by genotyping almost 4 million SNPs in 269⁎ Corresponding author. Fax: +1 414 456 6516.
E-mail address: molivier@mcw.edu (M. Olivier).
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doi:10.1016/j.ygeno.2006.04.004DNA samples from four distinct populations: 30 trios (60
independent individuals) from the Yoruba in Nigeria, a further
30 trios (60 independent individuals) from the Centre d'Etude
du Polymorphisme Humain (CEPH) collection (Utah, USA), 45
independent Han Chinese individuals, and 44 independent
Japanese individuals (http://www.hapmap.org [6]). The goal
now is to use this information to help determine sequence
variants that affect disease and ultimately develop diagnostic
tools and identify targets for therapeutic intervention [6,7].
However, caution must be exercised in the widespread
application of HapMap data without first ensuring its
applicability to other populations. Indeed this need to confirm
patterns of LD and tagSNPs is pointed out in the original
HapMap publication [7], though it need be done only in a subset
of 30–40 unrelated individuals as greater numbers do not result
in a significant improvement in performance [8].
There are a number of reports comparing LD patterns
between populations, though these are generally restricted to a
comparison of different ethnic groups in which variation would
be expected due to altered population histories and geographical
restrictions. De La Vega et al. [9] compared the LD patterns of
four major human populations across chromosomes 6, 21, and
22. They detected over one-third more LD in out-of-Africa
Table 1
Genotyped single-nucleotide polymorphism (SNP) density along the 2.5, 0.7,
and 1.8 Mb regions of chromosome 7 studied in the CEPH and MRC-OB
cohorts and the density of SNPs genotyped in both cohorts
Region Size
(Mb)
CEPH MRC-OB Shared
No. of
SNPs
SNP
density
(kb/SNP)
No. of
SNPs
SNP
density
(kb/SNP)
No. of
SNPs
SNP
density
(kb/SNP)
A 2.5 810 3.1 439 5.6 355 7.0
B 0.7 258 2.9 194 3.8 162 4.6
C 1.8 597 3.1 415 4.4 371 5.0
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LD remained similar. However, the authors also indicated that a
significant proportion of haplotypes within LD blocks was not
shared between populations, suggesting that markers for
association studies may need to be selected from individual
populations. Using a denser set of SNPs to compare a 10 Mb
region of chromosome 20, Evans and Cardon [10] were able to
demonstrate population-specific variations suggesting an al-
tered recombination history or other historical factors affecting
recombination. However, in the same study [10] a comparison
of CEPH and UK unrelated samples generated very similar
results suggesting (at least for this region of chromosome 20)
that populations of close ancestry will demonstrate similar
patterns of recombination. This is supported by studies
comparing LD patterns of individual genes between European
populations [8,11]. Nejentsev et al. [11] compared the LD
patterns of the vitamin D receptor gene region between four
European populations and an African population. Patterns for
the European populations were identical, with greater evidence
for historical recombination and the breakup of LD blocks in the
African sample. Mueller et al. [8] compared eight populations
with the CEPH cohort over four gene regions on four
chromosomes and demonstrated that while there was good
general agreement in LD patterns between populations of
similar ancestry, those populations potentially isolated by
language and geography may have an altered recombination
history. In the most recent analysis published to date, Ribas et al.
[12] detected very similar patterns of LD between the HapMap
CEPH cohort and a sample of the Spanish population when they
analyzed LD patterns and tagSNPs across 175 cancer-related
genes. Despite all these studies, it remains to be seen if the close
correspondence in LD patterns observed within gene regions,
between the CEPH and other populations of similar ancestry,
holds true for extended regions of the genome.
A number of reports have been published of late investigat-
ing the applicability and suitability of the HapMap data as a
resource for interrogating LD patterns and selecting tagSNPs
[12–14]. A study of samples from cases of multiple sclerosis in
Australia demonstrated that the CEPH population can be used to
predict patterns of LD accurately and select tagSNPs [13]. Other
studies of worldwide populations have also indicated that
tagSNPs are transferable to other populations [15,16]. A 13-Mb
region of chromosome 1q was investigated, and while the
HapMap proved effective in selecting tagSNPs that allow the
capture of the majority of common (MAF >5%) SNPs when
applied to other cohorts, rarer variants were missed in the
analysis. This result was also supported by Taylor et al. [17],
who indicated that common haplotypes within up to 50% of
genes may be missed by the use of HapMap SNP data alone.
However, for single-gene studies, it is up to individual
researchers to determine whether the use (and/or detection) of
rare SNPs in fine-mapping efforts is warranted [14].
It was the goal of our study to examine the usefulness of the
HapMap data for the detailed analysis of QTL regions in a
disease study cohort. For this, we compared the genotyping data
from four QTL regions identified in a cohort of northern
European descent with the HapMap data for the CEPH cohort.We compared a 5-Mb region on chromosome 7, in addition to a
further 9.3 Mb distributed over three regions of two chromo-
somes. Our data suggest that the CEPH LD data from the
HapMap project do provide a good reference for studying other
cohorts of similar ancestry. Near identical patterns of LD in the
two cohorts were observed, and tagSNPs selected based on
HapMap CEPH data were able to capture 98% of SNPs at an
r2 > 0.8 in the disease study cohort.
Results
The two cohorts analyzed in this investigation were the well-
studied CEPH population of the HapMap Consortium study
(http://www.hapmap.org) and a subset of the Metabolic Risk
Complications of Obesity Genes (MRC-OB) project cohort
[18,19]. The CEPH cohort consists of 30 family trio samples
(two parents and a child) collected from residents of Utah, USA,
with Northern and Western European ancestry. The MRC-OB
cohort was recruited from the TOPS (Take Off Pounds Sensibly,
Inc.) membership and consisted of 22 family quads (two parents
and two children, one child of each sex when available). These
provided 120 (CEPH) and 88 (MRC-OB) independent founder
chromosomes for analysis and comparison.
A total of four genomic regions were investigated and
compared between the two cohorts. All regions were selected
from our initial linkage analysis of the MRC-OB cohort study.
A 5 Mb interval on chromosome 7q36.1–q36.3 (Table 1), split
into three regions (hereafter referred to as regions A, B, and C)
by two gaps in the genome sequence (153,708,283–
153,808,282 and 154,544,615–154,624,614 bp: UCSC May
2004 assembly), harbors a QTL for plasma triglyceride and low-
density lipoprotein (LDL) concentrations [19]. Two additional
regions on chromosome 12p13–p11 are located within a QTL
for high-density lipoprotein (HDL)-cholesterol [19] and are 3.7
and 2.9 Mb in size. The fourth region investigated was a 2.7 Mb
area of chromosome 14q12–q13 within a QTL for plasma
adiponectin levels (unpublished data).
Different strategies were used to select SNPs for genotyping
in the four regions. SNPs were selected for fine-mapping of the
QTL regions, and it is the ultimate goal to compare the success
of these different approaches for QTL fine-mapping. For the
QTL interval on chromosome 7, SNPs were selected across the
entire region regardless of the location of genes with the aim of
genotyping one SNP every 5 kb. First, individual tagSNPs were
selected for genotyping based on LD by applying the method of
409E.M. Smith et al. / Genomics 88 (2006) 407–414Carlson et al. [20] with an r2 cutoff of 0.8 to the data for the
CEPH population of the HapMap. For regions not contained in
an LD block, additional SNPs were chosen approximately every
5 kb, irrespective of measures of LD. Additionally, all reported
nonsynonymous SNPs for the genes in the interval were
included in the genotyping.
For the other QTL intervals investigated in our study, SNPs
were selected using a gene-centric approach with an emphasis
on putative functional SNPs. SNPs were selected only within
the coding region of all known genes and within 5 kb of the start
and stop codons. For the interval on chromosome 14,
approximately five SNPs per gene were selected from the
following categories (in order of priority): nonsynonymous
SNPs, promoter SNPs, putative splice site-altering SNPs, and
synonymous SNPs in the coding sequence. For the two regions
on chromosome 12, synonymous SNPs were not included, and
additional tagSNPs based on LD were selected, again using the
method of Carlson et al. [20] within the genic regions. Future
investigations of the results obtained in our studies will allow
the examination of QTL fine-mapping approaches; however,
these analyses are outside the scope of the present investigation.
For the region on chromosome 7, a total of 1048 SNPs were
genotyped for each sample of the MRC-OB panel. This
consisted of 439 SNPs in region A (2.5 Mb), 194 SNPs in
region B (0.7 Mb), and 415 SNPs in region C (1.8 Mb). Of
these, 888 had corresponding genotypes in the CEPH cohort of
the HapMap: 355, 162, and 371 in regions A, B, and C,
respectively (Table 1). This resulted in an overall shared SNP
density of 1 SNP per 5.5 kb for the entire region. When split into
regions A, B, and C the shared SNP density was 1 SNP per
7.0 kb, 4.6 kb, and 5.0 kb, respectively (Table 1).
On chromosome 12 a total of 1055 SNPs were genotyped in
the MRC-OB cohort; 603 in the 3.7 Mb region of chromosome
12p13 and 452 in the 2.9 Mb region of chromosome 12p12–
p11. Of these, 1023 (584 and 439 on chromosomes 12p13 and
12p12–p11, respectively) had corresponding genotypes in the
CEPH cohort (Table 2).
Finally, on chromosome 14, 354 SNPs were genotyped in the
MRC-OB cohort; 348 of these had corresponding CEPH
genotypes (Table 2).Table 2
Genotyped single-nucleotide polymorphism (SNP) density in the CEPH and
MRC-OB cohorts and those genotyped in both cohorts, in the 3.7, 2.9, and
2.7 Mb regions of chromosomes 12p13, 12p12–p11, and 14q12–q13,
respectively
Chromosome Population Region
size (Mb)
No. of
SNPs
No. of
genes
SNPs/gene
Mean
(range)
Median
12p13 CEPH 3.7 1697 37 45.9 (4–275) 19
MRC-OB 3.7 603 37 16.3 (3–95) 9
Shared 3.7 584 37 15.8 (3–92) 8
12p12–p11 CEPH 2.9 1229 26 47.3 (1–165) 40
MRC-OB 2.9 452 26 17.4 (1–68) 13.5
Shared 2.9 439 26 16.9 (1–68) 13
14q12–q13 CEPH 2.7 1076 13 82.8 (1–378) 45
MRC-OB 2.7 354 13 27.2 (1–181) 6
Shared 2.7 348 13 26.8 (1–180) 5Linkage disequilibrium maps were constructed and tagSNPs
determined for all data, based on phased parental haplotypes and
for datasets restricted to SNPs with a MAF greater than 5%.
Average minor allele frequencies for both populations were
consistent over all chromosomes investigated (average MAF
0.25); and the value increased slightly for the restricted dataset,
due to the removal of SNPs with a lowMAF. AMAF cutoff level
of 5% reduced the number of SNPs in chromosome 7 regions A,
B, and C by 54, 16, and 33 (15.2, 9.9, and 8.9%), respectively.
The number of SNPs in the other regions studied were reduced
by 6.8% (12p13), 3.6% (12p12–p11), and 5.5% (14q12–q13).
LD comparison
Linkage disequilibrium in the two cohorts was compared
visually by contrasting the patterns generated from the genotype
data of SNPs typed in both cohorts (Fig. 1). This comparison of
shared SNPs between cohorts resulted in a total of 144,511 pair-
wise comparisons across chromosome 7 (62,835, 13,041, and
68,635 in regions A, B, and C, respectively). There were
266,377 pair-wise comparisons along chromosomes 12p13 and
12p12–p11 each. On chromosome 14, the number of pair-wise
comparisons was 60,378.
Almost identical patterns of LD were observed, with
blocks of high LD interspersed by regions of little or no LD in the
same areas of the genome in both groups (Supplementary Figs.
S1–S3). The correspondence in patterns is striking and is a clear
indicator of the genetic similarity of the cohorts.
When the pair-wise measures of LD (|D′| and r2) between
adjacent SNPs are compared between the two cohorts across all
regions studied 6.8% (|D′|) and 6.2% (r2) fall outside the 95%
confidence intervals (Fig. 2). This indicates that few SNPs
compared in our study differ significantly between the two
groups with respect to extent of LD. This is further supported by
the high Spearman rank correlation values of r2 obtained
between the two cohorts (Table 3), indicating almost identical
LD patterns between the two groups. For the regions
investigated on chromosomes 12 and 14 the values are greater
than 0.95, whereas for regions A, B, and C on chromosome 7
the values are 0.88, 0.91, and 0.95, respectively. This observed
variation in the correlation may be evidence for a (albeit small)
population difference between the two groups and could be
caused by population stratification. However, this result may
also be influenced by the reduced shared SNP density in region
A of chromosome 7 relative to the other regions. Furthermore,
analysis of the variation in measures of LD (|D′| and r2) between
the two groups relative to location within the regions studied
(Fig. 3; Supplementary Figs. S4 and S5) demonstrates no clear
pattern of localized variation, with differences distributed
seemingly randomly throughout the regions investigated.
TagSNP analysis
The use of tagSNPs for both haplotype and whole genome
tagging and the choice of selection algorithm are currently the
subject of intense debate [20,21]. While an analysis of the
relative merits of different strategies was outside the scope of
Fig. 1. Patterns of linkage disequilibrium (LD) detected in the CEPH and MRC-OB cohorts along (A) a 2.5 Mb, (B) a 0.7 Mb, and (C) a 1.8 Mb stretch of chromosome
7q36. A, B, and C depict the regions studied around physical gaps in the genome. The horizontal white bar represents the genome, with tick marks indicating the
approximate positions of genotyped SNPs. The angled lines connect the SNP positions in the genome to their location in the LD plot. Red squares indicate complete
LD; shades of pink/red, some but not complete LD; blue squares, complete LD with a reduced lod score (and so confidence); and white squares, no apparent LD.
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algorithm (Tagger [21]) to select tagSNPs for our QTL intervals.
TagSNPs were determined based on the LD patterns of the
subset of shared SNPs in the CEPH cohort. These were selectedfor all SNPs studied and also for a set restricted to a MAF >5%
(Table 4). We are merely using the concordance of tagSNPs
across the two sample cohorts as a measure of LD and haplotype
similarity and it is clear that other algorithms would select
Fig. 2. Correlation of (A) |D′| and (B) r2 between adjacent SNPs with a minor
allele frequency >5%, present in all genomic regions studied, in the CEPH and
MRC-OB cohorts. Each data point represents a single pair-wise comparison
between adjacent SNPs; the shaded area indicates the extent of the 95%
confidence interval of the mean.
Table 3
Spearman rank correlations for r2 (|D′|) between the CEPH and the MRC-OB
cohorts for the chromosomal regions indicated
Region 7A 7B 7C 12p13 12p12–p11 14q12–q13
7A 0.88
(0.70)
7B 0.91
(0.72)
7C 0.95
(0.72)
12p13 0.97
(0.73)
12p12–p11 0.99
(0.73)
14q12–q13 0.99
(0.81)
411E.M. Smith et al. / Genomics 88 (2006) 407–414different subsets of SNPs as tagSNPs. Our analysis did not
intend to identify the optimal set of tagSNPs across the QTL
intervals.
The proportion of tagSNPs selected remained relatively high
(>74%) across all regions investigated on chromosome 7 and
was greater than 92% on chromosomes 12 and 14 (Supple-
mentary Table ST4). This high rate of tagSNP selection is
probably due to the initial SNP selection strategies, which used
patterns of LD and an alternative tagSNP selection algorithm to
determine the SNPs for investigation. The increased rate on
chromosomes 12 and 14 is also likely to be influenced by the
selection of SNPs only within genes and an increased emphasis
on putative functional and rare SNPs.
Next, we determined the number of loci that would have
been captured in the MRC-OB cohort at an r2 of 0.8 or higher
had only the identified tagSNPs been genotyped. The tagSNPs
identified from the CEPH cohort proved to be an efficient
selection, as had just this subset of SNPs been genotyped in theMRC-OB cohort, they would have captured ∼98% of the
variability detected, at an r2 > 0.8 (Table 4). This proportion of
sites captured was consistent across all regions investigated,
demonstrating the potential benefit of selecting tagSNPs to
reduce genotyping burden and maintain the levels of informa-
tion generated.
Overall, the concordance between both the LD patterns and
the tagSNPs selected is encouraging and would suggest that
SNPs selected from the HapMap data would provide useful
information in the MRC-OB cohort.
Discussion
There are few reports available comparing the LD patterns
of the CEPH population used in the HapMap with other
Caucasian cohorts. Rather, comparisons are more commonly
made between populations from distinct geographical regions,
which may reasonably be expected to have altered histories
and resulting recombination patterns. However, one of the
major goals of the HapMap project was to provide SNP LD
data that could aid in the design of studies into the genetic
causes of disease. For this, patterns detected by the HapMap
must be confirmed in independent populations before they are
used extensively as the “gold standard” [7]. This has been
done for regions on chromosomes 1q, 4q, 6p, 10q, and 20q
[8,10] in selected population cohorts, and it is likely that as
more regions are investigated further data will emerge on this
aspect of study.
In our study the close correspondence of LD patterns over all
regions investigated between the two groups is striking,
suggesting that the CEPH data indeed are useful as a reference
dataset for SNP selection in our MRC-OB cohort and possibly
in other populations of northern European descent. This
compares well with the overall results of Evans and Cardon
[10], who examined a 10 Mb stretch of chromosome 20q and
demonstrated a high correlation between CEPH and UK
unrelated samples. However, these authors also indicated that
while measures of r2 were closely matched between the two
populations, |D′| values were more variable [10]. This
discrepancy in LD measures may be due to variation in the
MAFs of individual SNPs [22]. The greater correspondence of
Fig. 3. Variation in the measures of linkage disequilibrium, |D′| (circles) and r2 (triangles), of adjacent SNPs, between the CEPH and the MRC-OB cohorts, relative to
chromosomal position along the 5-Mb region of chromosome 7q36 studied.
412 E.M. Smith et al. / Genomics 88 (2006) 407–414|D′| values detected between the CEPH samples and our MRC-
OB cohort therefore indicates not only similar patterns of LD
but also a greater similarity between allele frequencies at the
loci investigated. This suggests that while the MRC-OB
families were selected through the initial identification of an
affected obese individual, there is little or no population
stratification affecting overall LD patterns. The potential
variation between U.S. individuals of northern European
ancestry and Europeans has been demonstrated previously
[23]. These studies suggested that the European haplotype
blocks may have been broken up in U.S. samples due to recent
admixture with other populations. Mueller et al. [8] compared a
total of 749 kb, distributed over four chromosomal regions, of
the CEPH population of the HapMap to eight other European
populations. They determined that LD block structure, defined
on the basis of a standard algorithm [3], was similar in some
cohorts, but for isolated and peripheral populations the CEPH
data were less informative. Other studies of LD in EuropeanTable 4
Number of single-nucleotide polymorphisms (SNPs) selected as tagSNPs in the
CEPH cohort and the percentage of SNPs captured in the MRC-OB cohort for
the three regions of chromosome 7 studied
Region MAF No. of SNPs No. (%) of tagSNPs % captured in MRC-OBa
A 0.00 355 292 (82.3) 98.6
0.05 301 238 (79.1) 98.3
B 0.00 162 122 (75.3) 99.4
0.05 146 109 (74.7) 96.3
C 0.00 371 278 (74.9) 99.7
0.05 338 253 (74.9) 97.3
a Percentage of SNPs captured in the MRC-OB cohort at an r2 > 0.8 when
using the tagSNPs selected from the CEPH cohort.populations have consistently reported very little variation
between individuals [11,24].
A further use of the HapMap is as a means of selecting
tagSNPs for interrogating genomic regions in other populations,
potentially reducing the amount of genotyping required.
Previous studies into the transferability of tagSNPs have
yielded conflicting results, though this is likely to be related to
the populations and genomic regions investigated. Carlson et al.
[20], studying Europeans and African Americans, determined
that tagSNPs should be selected separately for populations with
different ancestries. This agrees with Nejentsev et al. [11], who
indicated that tagSNPs were transferable between European
populations, but not between Europeans and Gambians.
However, Mueller et al. [8] demonstrated that while tagSNPs
determined from the CEPH cohort performed well when used to
interrogate three gene regions in Europeans, local samples were
more effective at a fourth locus, suggesting some loci are
conserved within subpopulations.
In the present study, over 80% of sites selected as tagSNPs
from the CEPH cohort were able to capture the vast majority of
SNPs in the MRC-OB cohort. This supports the use of the
CEPH cohort as a reference population for studies attempting to
interrogate disease-associated QTL.
To summarize, we have confirmed the patterns of LD
present in the CEPH population of the HapMap in areas of
chromosomes 7q, 12p, and 14q totaling 14.3 Mb, in an
independent population of northern European descent. The LD
patterns and identified tagSNPs are highly similar for all
regions studied. While it remains to be seen whether this
similarity can be confirmed for other study cohorts, our study
confirms the usefulness of the CEPH population of the
HapMap for selecting SNPs in disease study cohorts of similar
413E.M. Smith et al. / Genomics 88 (2006) 407–414ancestry, at least for the regions examined on chromosomes 7q,
12p, and 14q.
Materials and methods
Study populations
We have based our analyses on two populations genotyped on a
corresponding set of SNPs. The first is the CEPH population genotyped by
the International HapMap Consortium [6,7] and the data for 2259 markers
downloaded from the HapMap Web site (http://www.hapmap.org; HapMap
Public Release 16c.1); this included 30 family trios with 120 independent
founder chromosomes. The second sample was a subset of the MRC-OB
project cohort recruited from the TOPS membership as described previously
[18,19]. Briefly, families with at least two obese siblings (body mass index
(BMI) >30), the availability of one (preferably both) parent, and one or more
never obese sibling (BMI <27) were recruited from the TOPS membership in
10 Midwestern U.S. states. A questionnaire gathered health information from
all individuals, and phenotypic measurements included BMI, waist and hip
circumferences, fasting plasma glucose levels, insulin and insulin:glucose
ratio, cholesterol, LDL-cholesterol, HDL-cholesterol, and plasma triglyceride
levels. From the initial population of 2209 individuals distributed over 507
Caucasian families of predominantly northern European ancestry, 22 family
quads comprising both parents and two offspring (one of each gender when
available) were selected without consideration of obesity or other phenotypes,
giving a total of 88 independent founder chromosomes. All protocols have
been approved by the Institutional Review Board of the Medical College of
Wisconsin.
SNP selection
We selected four genomic regions for analysis based on previously identified
QTL for traits characteristic of the metabolic syndrome. Different SNP selection
strategies were used for each region.
Chromosome 7
SNPs were selected based on the LD patterns of the CEPH population
genotyped as part of the HapMap project. Individual tagSNPs were chosen by
applying the tagging algorithm of Carlson et al. [20] with an r2 cutoff of 0.8 to
the CEPH data. In addition, SNPs were selected every 5 kb in regions not
contained in an LD block, independent of any measures of LD. Also, all
nonsynonymous SNPs in the region were included in the list of SNPs to be
genotyped. The aim was to genotype one SNP every 5 kb.
Chromosome 12
In contrast to chromosome 7, the SNPs selected in the two regions on
chromosome 12 were located only within known genes and ±5 kb of the start
and stop codons. Nonsynonymous SNPs, promoter SNPs, and putative splice
site-altering SNPs were selected. In addition, LD data derived from the CEPH
population of the HapMap were used as the basis for selecting tagSNPs in the
genic regions using the algorithm of Carlson et al. [20].
Chromosome 14
For this interval, SNPs were selected using a gene-centric approach with an
emphasis on putative functional SNPs. SNPs were again selected within the
coding region of all known genes and within 5 kb of the start and stop codons.
Approximately five SNPs per gene were selected from the following categories
(in order of priority): nonsynonymous SNPs, promoter SNPs, putative splice
site-altering SNPs, and synonymous SNPs in the coding sequence.
Genotyping procedures
Genomic DNA was isolated from whole blood using commercial kits
(Puregene, Gentra Systems, Minneapolis, MN, USA) and normalized to 150 ng
μl−1 for genotyping on a custom-designed 3K GeneChip Universal Tag Array
with the Affymetrix GeneChip Scanner 3000 7GMegAllele System (Affymetrix,
Santa Clara, CA, USA) based on Molecular Inversion Probe technology [25,26](ParAllele Bioscience, Inc.), as recommended by the manufacturer. Briefly,
probes are hybridized to genomic DNA flanking the location of a SNP, an
enzymatic gap-fill reaction circularizes the probes in an allele-specific manner,
and the probes are then separated from unreacted and cross-reacted probes by an
exonuclease reaction. The circularized (or “padlocked”) probes are inverted and
amplified by PCR and an allele-specific label is added; samples are then
hybridized to GeneChip Universal Tag Arrays and scanned four times (once for
each allele: A, C, G, T). Samples were processed at the rate of 48/day with one
positive and one negative control included in every 48 samples. Data were
processed using the GeneChip Operating System version 1.3.0.031 (Affymetrix)
and genotypes determined by using the Cluster Fit function of TrueCall Analyzer
version 7.0.0.22 (ParAllele BioScience, Inc., Santa Clara, CA, USA).
Data analysis
Pedigree information and genotypes for the CEPH cohort were downloaded
from the HapMap home page (http://www.hapmap.org), and genotypes for the
MRC-OB cohort were exported from TrueCall Analyzer version 7.0.0.22
(ParAllele BioScience); data files were transformed to linkage format for further
analysis. Data were initially checked for relationship and genotyping errors
using PedCheck version 1.1 [27], errors were corrected by removing all
genotypes for a family at a discrepant SNP as it was not possible to determine
unambiguously which individual genotype was incorrect. Parental haplotypes
were determined using the haplotype function of GeneHunter version 2.1_r6
(http://www.fhcrc.org/science/labs/kruglyak/Downloads/) and analyzed further
using Haploview version 3.2 [28]. TagSNPs were determined using Tagger [21],
implemented in Haploview version 3.2 [28]. Aggressive tagging using two- and
three-marker haplotypes with a lod threshold of 3.0 was performed. These
parameters were used to maintain a high tagging efficiency with minimal loss of
power and ensure that selected tagSNPs were in strong LD with all predicted
alleles.
To investigate the variability associated with fine-scale measures of LD
between the two populations, we calculated pair-wise LD measures (|D′| and r2)
between adjacent markers in each population and the Pearson correlation
between the two populations.Acknowledgments
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